Promis Neurosciences Inc (PMN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 768 | 1,252 | 1,844 | 1,304 | 538 |
| Marketable Securities | 31 | 32 | 32 | 32 | 31 |
| Receivables | 30 | 56 | 42 | 36 | 35 |
| TOTAL | $926 | $1,526 | $2,244 | $1,626 | $678 |
| Non-Current Assets | |||||
| PPE Net | 74 | N/A | 2 | 2 | 1 |
| Investments And Advances | 2 | 0 | 0 | 0 | 0 |
| Intangibles | 31 | 36 | 42 | 48 | 52 |
| TOTAL | $108 | $36 | $44 | $49 | $53 |
| Total Assets | $1,034 | $1,563 | $2,288 | $1,675 | $731 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 416 | 1,101 | 550 | 201 | 587 |
| Accrued Expenses | 44 | 162 | 362 | 291 | N/A |
| Other current liabilities | 1,332 | N/A | 485 | N/A | N/A |
| TOTAL | $1,792 | $1,263 | $1,396 | $492 | $679 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $1,792 | $1,263 | $1,396 | $492 | $679 |
| Shareholders' Equity | |||||
| Common Shares | 39,372 | 36,951 | 34,890 | 28,906 | 24,704 |
| Retained earnings | -53,187 | -49,425 | -44,893 | -37,044 | -31,720 |
| Other shareholders' equity | 6,823 | 6,690 | 4,731 | 3,203 | 1,119 |
| TOTAL | $-758 | $300 | $892 | $1,183 | $52 |
| Total Liabilities And Equity | $1,034 | $1,563 | $2,288 | $1,675 | $731 |